Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Cheesecake Factory (CAKE) PT Raised to $57 at Maxim Group; Bottom-Line Visibility Improving
-
Actinium Pharmaceuticals Announces Commencement of Rights Offering Subscription Period
-
Actinium Pharmaceuticals Announces Commencement of Rights Offering Subscription Period
-
Texas Roadhouse (TXRH) PT Raised to $67 at Maxim Group; '4Q17 EPS Beat on Mix of Strong Comps and Margin Expansion; Off to Solid Start in 2018'
-
Maxim Group Downgrades IntelliPharmaCeutics International (IPCI) to Hold
-
Tyler Tech (TYL) PT Raised to $220 at Maxim Group; 'Solid Bookings and Tax Reform'
-
Safe Bulkers (SB) PT Raised to $5.50 at Maxim Group; 'Strong Tradewinds to Buoy Shares'
-
Inpixon (INPX) Prices $18M Public Offering
-
Inpixon Prices $18M Public Offering
-
Immutep Limited (IMMP) PT Lowered to $5 at Maxim Group
-
Inovio Pharmaceuticals (INO) PT Lowered to $8 at Maxim Group
-
Inpixon (INPX) Announces Public Offering
-
Inpixon Launches Public Offering
-
Sophiris Bio (SPHS) PT Lowered to $5 at Maxim Group
-
Sonoma Pharmaceuticals (SNOA) PT Lowered to $7 at Maxim Group
-
Adamis Pharmaceuticals (ADMP) PT Lowered to $5 at Maxim Group, Street Low, 'We are Adjusting our Timing & Increasing our Risk Rates'
-
Maxim Group Downgrades Galmed Pharmaceuticals (GLMD) to Hold
-
Chipotle (CMG) New CEO 'Checks All the Boxes' - Maxm
-
Interpace Diagnostics Group Inc (IDXG) PT Lowered to $3 at Maxim Group
-
IsoRay, Inc. (ISR) PT Lowered to $2 at Maxim Group; 'Remove "Technology Platform" Value as IsoRay is now a Commercial Company'
-
Chipotle turns to Taco Bell's 'Doritos Locos' chief as new CEO
-
Soleno Therapeutics Inc. (SLNO) PT Lowered to $4 at Maxim Group; 'Distressed Valuation Without Data Makes Raising Capital Difficult'
-
UPDATE: Maxim Group Downgrades MYnd Analytics (MYND) to Hold Amid Cash Burh
-
Athersys (ATHX) PT Lowered to $6 at Maxim Group; Few Catalysts in the Year Ahead
-
UPDATE: Maxim Group Downgrades ContraVir Pharma (CTRV) at Hold
-
Cytori Therapeutics, Inc. (CYTX) PT Lowered to $4 at Maxim Group Ahead of Binary Event
-
Helios and Matheson (HMNY) Prices Stock Offering at $5.50 w/Warrants
-
Helios and Matheson Analytics Announces Pricing of $105 Million Public Offering
-
Helios and Matheson (HMNY) Plans Public Offering of Common Stock, Warrants
-
Helios and Matheson Analytics Announces Proposed Public Offering of Common Stock and Warrants
-
Viveve Announces Closing of Public Offering of Shares of Common Stock
-
Maxim Group Downgrades Determine (DTRM) to Sell
-
Actinium Pharmaceuticals Reminds Investors of Today’s Deadline to be a Shareholder of Record
-
Actinium Pharmaceuticals Reminds Investors of Today’s Deadline to be a Shareholder of Record
-
Maxim Group Upgrades Control4 Corporation (CTRL) to Buy
-
Virtusa (VRTU) PT Raised to $59 at Maxim Group
-
Viveve Medical (VIVE) Prices 10M Share Common Offering at $3/Sh
-
Viveve Announces Pricing of Public Offering of Shares of Common Stock
-
Xplore Technologies (XPLR) PT Raised to $6 at Maxim Group
-
Actinium Pharmaceuticals Reminds Investors of Record Date for Rights Offering
-
Actinium Pharmaceuticals Reminds Investors of Record Date for Rights Offering
-
Chipotle Mexican Grill (CMG) PT Lowered to $410 at Maxim Group
-
Viking Therapeutics Announces Closing of Public Offering of Common Stock
-
Wall Street says Starbucks has too many stores, prices too high
-
Viking Therapeutics (VKTX) Prices 11M Shares at $5
-
Viking Therapeutics Announces Pricing of $55.0 Million Public Offering of Common Stock
-
Sensus Healthcare (SRTS) PT Raised to $9 at Maxim Group
-
Maxim Group Upgrades Tableau Software (DATA) to Hold
-
Actinium Pharma (ATNM) Announces Rights Offering
-
Actinium Pharmaceuticals Announces Rights Offering

